These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1735680)
21. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study. Aboagye EO; Dillehay LE; Bhujwalla ZM; Lee DJ Radiat Oncol Investig; 1998; 6(6):249-54. PubMed ID: 9885940 [TBL] [Abstract][Full Text] [Related]
22. Correlations between in vivo 31P NMR spectroscopy measurements, tumor size, hypoxic fraction and cell survival after radiotherapy. Fu KK; Wendland MF; Iyer SB; Lam KN; Engeseth H; James TL Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1341-50. PubMed ID: 2370183 [TBL] [Abstract][Full Text] [Related]
23. Correlation of radiobiological assays of hypoxic fraction with phosphorus-31 magnetic resonance spectroscopy across multiple tumor lines. Li SJ; Jin GY; Fish BL; Moulder JE Radiat Res; 1995 Jul; 143(1):45-53. PubMed ID: 7597143 [TBL] [Abstract][Full Text] [Related]
24. Blood flow modification in the SCCVII tumor: effects of 5-hydroxytryptamine, hydralazine, and propranolol. Peters CE; Chaplin DJ Int J Radiat Oncol Biol Phys; 1992; 22(3):463-5. PubMed ID: 1735679 [TBL] [Abstract][Full Text] [Related]
25. 31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models. Robinson SP; van den Boogaart A; Maxwell RJ; Griffiths JR; Hamilton E; Waterton JC Br J Cancer; 1998 Jun; 77(11):1752-60. PubMed ID: 9667643 [TBL] [Abstract][Full Text] [Related]
26. Effects of hydralazine on in vivo tumor energy metabolism, hematopoietic radiation sensitivity, and cardiovascular parameters. Okunieff P; Walsh CS; Vaupel P; Kallinowski F; Hitzig BM; Neuringer LJ; Suit HD Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1145-8. PubMed ID: 2715061 [TBL] [Abstract][Full Text] [Related]
27. Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine. Wood PJ; Sansom JM; Butler SA; Stratford IJ; Cole SM; Szabo C; Thiemermann C; Adams GE Cancer Res; 1994 Dec; 54(24):6458-63. PubMed ID: 7987843 [TBL] [Abstract][Full Text] [Related]
28. Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension. Tozer GM; Maxwell RJ; Griffiths JR; Pham P Br J Cancer; 1990 Oct; 62(4):553-60. PubMed ID: 2223572 [TBL] [Abstract][Full Text] [Related]
29. Effects of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging. Bhujwalla ZM; Shungu DC; Glickson JD Magn Reson Med; 1996 Aug; 36(2):204-11. PubMed ID: 8843373 [TBL] [Abstract][Full Text] [Related]
30. Spin-lattice relaxation time of inorganic phosphate in human tumor xenografts measured in vivo by 31P-magnetic resonance spectroscopy. Influence of oxygen tension. Olsen DR; Lyng H; Petersen S; Rofstad EK Acta Oncol; 1995; 34(3):339-43. PubMed ID: 7779420 [TBL] [Abstract][Full Text] [Related]
31. 31P MRS to monitor the induction of tumor hypoxia by the modification of the oxygen affinity of hemoglobin using BW 589C. Kalra R; Bremner JC; Wood PJ; Sansom J; Counsell CJ; Stratford IJ; Adams GE Int J Radiat Oncol Biol Phys; 1994 May; 29(2):285-8. PubMed ID: 8195020 [TBL] [Abstract][Full Text] [Related]
32. Histological evidence for nonperfused vasculature in a murine tumor following hydralazine administration. Trotter MJ; Acker BD; Chaplin DJ Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):785-9. PubMed ID: 2777668 [TBL] [Abstract][Full Text] [Related]
33. Radiation-induced changes in phosphorus T1 values in human melanoma xenografts studied by 31P-MRS. Olsen DR; Petersen SB; Rofstad EK Magn Reson Imaging; 1997; 15(10):1187-92. PubMed ID: 9408139 [TBL] [Abstract][Full Text] [Related]
34. Effects of oxygen on the metabolism of murine tumors using in vivo phosphorus-31 NMR. Okunieff P; McFarland E; Rummeny E; Willett C; Hitzig B; Neuringer L; Suit H Am J Clin Oncol; 1987 Dec; 10(6):475-82. PubMed ID: 3687832 [TBL] [Abstract][Full Text] [Related]
35. The effect of hydralazine on blood flow and misonidazole toxicity in human tumour xenografts. Guichard M; Lespinasse F; Trotter M; Durand R; Chaplin D Radiother Oncol; 1991 Feb; 20(2):117-23. PubMed ID: 2031087 [TBL] [Abstract][Full Text] [Related]
36. Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy. Sijens PE; Baldwin NJ; Ng TC Magn Reson Med; 1991 Jun; 19(2):373-85. PubMed ID: 1908937 [TBL] [Abstract][Full Text] [Related]
37. Comparative effects of hydralazine on perfusion of KHT tumor, kidney and liver and on renal function in mice. Honess DJ; Bleehen NM Int J Radiat Oncol Biol Phys; 1992; 22(5):953-61. PubMed ID: 1555988 [TBL] [Abstract][Full Text] [Related]
38. Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. Tozer GM; Bhujwalla ZM; Griffiths JR; Maxwell RJ Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):155-64. PubMed ID: 2912937 [TBL] [Abstract][Full Text] [Related]
39. Detection of tumors with 19F magnetic resonance imaging. Ratner AV; Muller HH; Bradley-Simpson B; Johnson DE; Hurd RE; Sotak C; Young SW Invest Radiol; 1988 May; 23(5):361-4. PubMed ID: 3384616 [TBL] [Abstract][Full Text] [Related]
40. Effects of vasodilators on the signal intensity of perfluorocarbon monitored by in vivo 19F-NMR spectroscopy. Sogabe T; Imaizumi T; Mori T; Tominaga M; Koga K; Yabuuchi Y Magn Reson Imaging; 1997; 15(3):341-5. PubMed ID: 9201682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]